| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.32e-05 | 18 | 52 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 5.21e-05 | 28 | 52 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.22e-04 | 37 | 52 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.39e-04 | 441 | 52 | 7 | GO:0016887 | |
| GeneOntologyMolecularFunction | magnesium ion binding | 4.50e-04 | 247 | 52 | 5 | GO:0000287 | |
| GeneOntologyMolecularFunction | single-stranded DNA endodeoxyribonuclease activity | 5.09e-04 | 13 | 52 | 2 | GO:0000014 | |
| GeneOntologyMolecularFunction | peptidase activator activity | 8.06e-04 | 70 | 52 | 3 | GO:0016504 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 8.06e-04 | 70 | 52 | 3 | GO:0003777 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 8.23e-04 | 775 | 52 | 8 | GO:0017111 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.01e-03 | 614 | 52 | 7 | GO:0140657 | |
| GeneOntologyMolecularFunction | endopeptidase activator activity | 1.11e-03 | 19 | 52 | 2 | GO:0061133 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 1.37e-03 | 839 | 52 | 8 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 1.38e-03 | 840 | 52 | 8 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 1.38e-03 | 840 | 52 | 8 | GO:0016818 | |
| GeneOntologyMolecularFunction | ribonucleoprotein complex binding | 2.02e-03 | 206 | 52 | 4 | GO:0043021 | |
| GeneOntologyCellularComponent | inner dynein arm | 2.70e-04 | 10 | 52 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | dynein complex | 3.29e-04 | 54 | 52 | 3 | GO:0030286 | |
| Domain | Dynein_heavy_chain_D4_dom | 6.84e-06 | 14 | 51 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 6.84e-06 | 14 | 51 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 6.84e-06 | 14 | 51 | 3 | IPR013602 | |
| Domain | DHC_N2 | 6.84e-06 | 14 | 51 | 3 | PF08393 | |
| Domain | MT | 6.84e-06 | 14 | 51 | 3 | PF12777 | |
| Domain | AAA_8 | 6.84e-06 | 14 | 51 | 3 | PF12780 | |
| Domain | DHC_fam | 8.53e-06 | 15 | 51 | 3 | IPR026983 | |
| Domain | Dynein_heavy_dom | 8.53e-06 | 15 | 51 | 3 | IPR004273 | |
| Domain | Dynein_heavy | 8.53e-06 | 15 | 51 | 3 | PF03028 | |
| Domain | Transc_factor_DP_C | 2.19e-05 | 3 | 51 | 2 | IPR014889 | |
| Domain | DP | 2.19e-05 | 3 | 51 | 2 | PF08781 | |
| Domain | DP | 2.19e-05 | 3 | 51 | 2 | SM01138 | |
| Domain | Transcrpt_fac_DP | 2.19e-05 | 3 | 51 | 2 | IPR015648 | |
| Domain | E2F_TDP | 3.96e-04 | 11 | 51 | 2 | PF02319 | |
| Domain | E2F_TDP | 3.96e-04 | 11 | 51 | 2 | SM01372 | |
| Domain | E2F_WHTH_DNA-bd_dom | 3.96e-04 | 11 | 51 | 2 | IPR003316 | |
| Domain | AAA+_ATPase | 6.39e-04 | 144 | 51 | 4 | IPR003593 | |
| Domain | AAA | 6.39e-04 | 144 | 51 | 4 | SM00382 | |
| Domain | ATPase_dyneun-rel_AAA | 6.51e-04 | 14 | 51 | 2 | IPR011704 | |
| Domain | AAA_5 | 6.51e-04 | 14 | 51 | 2 | PF07728 | |
| Domain | - | 3.95e-03 | 746 | 51 | 7 | 3.40.50.300 | |
| Domain | Pkinase_C | 4.58e-03 | 37 | 51 | 2 | IPR017892 | |
| Domain | SET | 5.60e-03 | 41 | 51 | 2 | PF00856 | |
| Domain | TPR_repeat | 5.73e-03 | 133 | 51 | 3 | IPR019734 | |
| Domain | Pkinase_C | 5.87e-03 | 42 | 51 | 2 | PF00433 | |
| Domain | SET | 7.01e-03 | 46 | 51 | 2 | SM00317 | |
| Domain | P-loop_NTPase | 7.87e-03 | 848 | 51 | 7 | IPR027417 | |
| Domain | TPR-contain_dom | 7.98e-03 | 150 | 51 | 3 | IPR013026 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 7.35e-05 | 27 | 43 | 3 | M47755 | |
| Pathway | REACTOME_ACTIVATION_OF_NOXA_AND_TRANSLOCATION_TO_MITOCHONDRIA | 9.04e-05 | 5 | 43 | 2 | M26903 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 3.00e-04 | 43 | 43 | 3 | M47669 | |
| Pathway | REACTOME_ACTIVATION_OF_PUMA_AND_TRANSLOCATION_TO_MITOCHONDRIA | 3.23e-04 | 9 | 43 | 2 | M26946 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 3.43e-04 | 45 | 43 | 3 | M47670 | |
| Pubmed | RANBP2 SF3B3 DST SUGT1 NSA2 RRS1 NUP133 GEMIN4 PSME2 DDX24 SEC61A1 GCN1 MX1 PTCD3 | 2.16e-08 | 1440 | 53 | 14 | 30833792 | |
| Pubmed | 4.79e-08 | 653 | 53 | 10 | 22586326 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANBP2 DIS3L2 SF3B3 DST SUGT1 NSA2 RRS1 NUP133 GEMIN4 DDX24 GCN1 CAP1 PTCD3 | 8.70e-08 | 1353 | 53 | 13 | 29467282 |
| Pubmed | 1.32e-07 | 547 | 53 | 9 | 37267103 | ||
| Pubmed | 2.25e-07 | 418 | 53 | 8 | 34709266 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | DST SUGT1 LYPLAL1 NSA2 RRS1 ALDH1L2 MRPL37 NUP133 GEMIN4 AIP DDX24 SEC61A1 PTCD3 | 2.76e-07 | 1496 | 53 | 13 | 32877691 |
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 3.01e-07 | 92 | 53 | 5 | 15840729 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RANBP2 SF3B3 RRS1 MRPL37 NUP133 GEMIN4 DDX24 SEC61A1 GCN1 PRDM2 CAP1 PTCD3 | 1.20e-06 | 1425 | 53 | 12 | 30948266 |
| Pubmed | 1.20e-06 | 14 | 53 | 3 | 9373155 | ||
| Pubmed | CASP8AP2 SF3B3 CDC42BPA SUGT1 RRS1 MRPL37 NUP133 AIP DDX24 SEC61A1 TFDP1 PTCD3 | 1.87e-06 | 1487 | 53 | 12 | 33957083 | |
| Pubmed | ROCK2 RANBP2 SF3B3 CDC42BPA SUGT1 PSME2 DDX24 ME1 SEC61A1 GCN1 CAP1 | 2.30e-06 | 1247 | 53 | 11 | 27684187 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | ROCK2 RANBP2 SF3B3 MORF4L1 NUP133 GEMIN4 POLQ DDX24 SEC61A1 GCN1 PTCD3 | 3.05e-06 | 1284 | 53 | 11 | 17353931 |
| Pubmed | RANBP2 SF3B3 RESF1 SUGT1 MORF4L1 MRPL37 PEG3 AIP PSME2 DDX24 PTCD3 | 4.42e-06 | 1335 | 53 | 11 | 29229926 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RANBP2 SF3B3 DST CDC42BPA RRS1 MORF4L1 DDX24 SEC61A1 GCN1 PTCD3 | 4.71e-06 | 1082 | 53 | 10 | 38697112 |
| Pubmed | 4.90e-06 | 847 | 53 | 9 | 35850772 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 15282318 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 9000141 | ||
| Pubmed | DST CDC42BPA RESF1 NSA2 MORF4L1 MRPL37 DDX24 TFDP1 TFDP2 PRDM2 PTCD3 | 8.43e-06 | 1429 | 53 | 11 | 35140242 | |
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | 1.05e-05 | 931 | 53 | 9 | 27432908 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 1.08e-05 | 704 | 53 | 8 | 29955894 | |
| Pubmed | 1.12e-05 | 708 | 53 | 8 | 39231216 | ||
| Pubmed | Genomic cloning and chromosomal assignment of the E2F dimerization partner TFDP gene family. | 1.36e-05 | 4 | 53 | 2 | 9027491 | |
| Pubmed | E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. | 1.36e-05 | 4 | 53 | 2 | 9704927 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 17344417 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 8755520 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 1.50e-05 | 974 | 53 | 9 | 28675297 | |
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 39056782 | ||
| Pubmed | 2.57e-05 | 228 | 53 | 5 | 30471916 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 2.81e-05 | 582 | 53 | 7 | 20467437 | |
| Pubmed | 3.07e-05 | 396 | 53 | 6 | 26687479 | ||
| Pubmed | Repression of transcriptional activity of C/EBPalpha by E2F-dimerization partner complexes. | 3.40e-05 | 6 | 53 | 2 | 20176812 | |
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 28049720 | ||
| Pubmed | 3.62e-05 | 408 | 53 | 6 | 33766124 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 3.81e-05 | 123 | 53 | 4 | 26912792 | |
| Pubmed | 4.35e-05 | 1116 | 53 | 9 | 31753913 | ||
| Pubmed | 4.76e-05 | 7 | 53 | 2 | 17098863 | ||
| Pubmed | 4.76e-05 | 7 | 53 | 2 | 29162624 | ||
| Pubmed | 4.76e-05 | 7 | 53 | 2 | 12588846 | ||
| Pubmed | 4.76e-05 | 7 | 53 | 2 | 7739537 | ||
| Pubmed | E2F-6, a member of the E2F family that can behave as a transcriptional repressor. | 4.76e-05 | 7 | 53 | 2 | 9501179 | |
| Pubmed | 4.82e-05 | 634 | 53 | 7 | 34591612 | ||
| Pubmed | Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation. | 5.33e-05 | 134 | 53 | 4 | 28695742 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 5.44e-05 | 1149 | 53 | 9 | 35446349 | |
| Pubmed | 6.03e-05 | 657 | 53 | 7 | 36180527 | ||
| Pubmed | 6.34e-05 | 8 | 53 | 2 | 16360038 | ||
| Pubmed | 7.18e-05 | 283 | 53 | 5 | 21903422 | ||
| Pubmed | 7.30e-05 | 284 | 53 | 5 | 29459677 | ||
| Pubmed | 7.82e-05 | 469 | 53 | 6 | 27634302 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 7.98e-05 | 934 | 53 | 8 | 33916271 | |
| Pubmed | 9.44e-05 | 300 | 53 | 5 | 28561026 | ||
| Pubmed | 1.00e-04 | 713 | 53 | 7 | 29802200 | ||
| Pubmed | 1.04e-04 | 971 | 53 | 8 | 33306668 | ||
| Pubmed | 1.07e-04 | 497 | 53 | 6 | 23414517 | ||
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | 1.10e-04 | 499 | 53 | 6 | 22810586 | |
| Pubmed | 1.11e-04 | 162 | 53 | 4 | 15174051 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 1.19e-04 | 989 | 53 | 8 | 36424410 | |
| Pubmed | 1.24e-04 | 63 | 53 | 3 | 34718347 | ||
| Pubmed | 1.37e-04 | 1297 | 53 | 9 | 33545068 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 1.47e-04 | 330 | 53 | 5 | 33301849 | |
| Pubmed | 1.77e-04 | 1049 | 53 | 8 | 27880917 | ||
| Pubmed | 2.05e-04 | 14 | 53 | 2 | 17531812 | ||
| Pubmed | 2.07e-04 | 1371 | 53 | 9 | 36244648 | ||
| Pubmed | 2.26e-04 | 195 | 53 | 4 | 19454010 | ||
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | 2.28e-04 | 571 | 53 | 6 | 37167062 | |
| Pubmed | FBXO3 Protein Promotes Ubiquitylation and Transcriptional Activity of AIRE (Autoimmune Regulator). | 2.36e-04 | 15 | 53 | 2 | 27365398 | |
| Pubmed | 2.49e-04 | 1103 | 53 | 8 | 34189442 | ||
| Pubmed | 2.59e-04 | 202 | 53 | 4 | 24639526 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 2.62e-04 | 1415 | 53 | 9 | 28515276 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 2.89e-04 | 208 | 53 | 4 | 33230847 | |
| Pubmed | 3.01e-04 | 1442 | 53 | 9 | 35575683 | ||
| Pubmed | 3.05e-04 | 17 | 53 | 2 | 24124579 | ||
| Pubmed | The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma. | 3.05e-04 | 17 | 53 | 2 | 23502783 | |
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 3.11e-04 | 212 | 53 | 4 | 33462405 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 3.11e-04 | 212 | 53 | 4 | 33853758 | |
| Pubmed | 3.13e-04 | 606 | 53 | 6 | 36538041 | ||
| Pubmed | CRISPR/Cas9-mediated Genomic Editing of Cluap1/IFT38 Reveals a New Role in Actin Arrangement. | 3.17e-04 | 213 | 53 | 4 | 29615496 | |
| Pubmed | 3.34e-04 | 216 | 53 | 4 | 31519766 | ||
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 3.40e-04 | 217 | 53 | 4 | 31685992 | |
| Pubmed | The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase. | 3.58e-04 | 220 | 53 | 4 | 34091597 | |
| Pubmed | 3.70e-04 | 222 | 53 | 4 | 37071664 | ||
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 3.96e-04 | 226 | 53 | 4 | 37839992 | |
| Pubmed | 3.96e-04 | 1497 | 53 | 9 | 31527615 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 4.01e-04 | 410 | 53 | 5 | 26949251 | |
| Pubmed | 4.11e-04 | 638 | 53 | 6 | 33239621 | ||
| Pubmed | 4.11e-04 | 638 | 53 | 6 | 31182584 | ||
| Pubmed | 4.42e-04 | 419 | 53 | 5 | 15635413 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 4.43e-04 | 910 | 53 | 7 | 36736316 | |
| Pubmed | 4.44e-04 | 233 | 53 | 4 | 37704626 | ||
| Pubmed | 4.52e-04 | 234 | 53 | 4 | 36243803 | ||
| Pubmed | 4.59e-04 | 98 | 53 | 3 | 34943047 | ||
| Pubmed | 5.87e-04 | 446 | 53 | 5 | 24255178 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | 5.95e-04 | 1257 | 53 | 8 | 37317656 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 5.95e-04 | 1257 | 53 | 8 | 36526897 | |
| Pubmed | SOCS2 Binds to and Regulates EphA2 through Multiple Mechanisms. | 6.43e-04 | 110 | 53 | 3 | 28883622 | |
| Pubmed | Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2 transcription network. | 6.60e-04 | 111 | 53 | 3 | 32683582 | |
| Pubmed | 6.68e-04 | 25 | 53 | 2 | 10601273 | ||
| Pubmed | 6.95e-04 | 113 | 53 | 3 | 30352685 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 7.19e-04 | 1294 | 53 | 8 | 30804502 | |
| Pubmed | 7.23e-04 | 26 | 53 | 2 | 12228227 | ||
| Pubmed | MxA interacts with and is modified by the SUMOylation machinery. | 7.80e-04 | 27 | 53 | 2 | 25447205 | |
| Interaction | SIRT7 interactions | RANBP2 DST NSA2 RRS1 NUP133 GEMIN4 PSME2 DDX24 GCN1 CAP1 PTCD3 | 2.44e-06 | 744 | 52 | 11 | int:SIRT7 |
| Interaction | NUP43 interactions | CASP8AP2 RANBP2 DST RESF1 SUGT1 RRS1 NUP133 DDX24 TFDP1 PRDM2 | 3.74e-06 | 625 | 52 | 10 | int:NUP43 |
| Interaction | RPS6KL1 interactions | 9.00e-06 | 51 | 52 | 4 | int:RPS6KL1 | |
| Interaction | KCNA3 interactions | ROCK2 RANBP2 SF3B3 DST CDC42BPA GEMIN4 POLQ SEC61A1 GCN1 PRDM2 CAP1 | 1.10e-05 | 871 | 52 | 11 | int:KCNA3 |
| Interaction | FBXL6 interactions | 1.62e-05 | 583 | 52 | 9 | int:FBXL6 | |
| Interaction | USP19 interactions | 4.75e-05 | 154 | 52 | 5 | int:USP19 | |
| Interaction | DUSP2 interactions | 5.66e-05 | 81 | 52 | 4 | int:DUSP2 | |
| Interaction | RNF2 interactions | RANBP2 SF3B3 NSA2 MORF4L1 NUP133 DDX24 GCN1 TFDP1 TFDP2 PTCD3 | 6.24e-05 | 866 | 52 | 10 | int:RNF2 |
| Interaction | KDM1A interactions | CASP8AP2 RANBP2 DST RESF1 SUGT1 GEMIN4 ZFP28 GCN1 TFDP1 PRDM2 | 1.24e-04 | 941 | 52 | 10 | int:KDM1A |
| Interaction | MCIDAS interactions | 1.36e-04 | 7 | 52 | 2 | int:MCIDAS | |
| Interaction | KLF12 interactions | 1.41e-04 | 194 | 52 | 5 | int:KLF12 | |
| Interaction | FGFR3 interactions | 1.55e-04 | 315 | 52 | 6 | int:FGFR3 | |
| Cytoband | 12p11.21 | 2.98e-04 | 22 | 53 | 2 | 12p11.21 | |
| GeneFamily | Dyneins, axonemal | 3.37e-06 | 17 | 32 | 3 | 536 | |
| GeneFamily | Transcription factor Dp family | 9.09e-06 | 3 | 32 | 2 | 987 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 9.90e-05 | 51 | 32 | 3 | 870 | |
| GeneFamily | Nucleoporins | 1.46e-03 | 32 | 32 | 2 | 1051 | |
| Coexpression | GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP | 2.48e-06 | 196 | 52 | 6 | M4928 | |
| Coexpression | GSE32986_UNSTIM_VS_GMCSF_STIM_DC_DN | 2.70e-06 | 199 | 52 | 6 | M8641 | |
| Coexpression | GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN | 4.67e-05 | 199 | 52 | 5 | M5242 | |
| Coexpression | PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN | 6.11e-05 | 107 | 52 | 4 | MM947 | |
| Coexpression | PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN | 6.57e-05 | 109 | 52 | 4 | M2451 | |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.26e-07 | 197 | 53 | 6 | e77016d64b1cac9825fec7cfe5071f1567401187 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-06 | 173 | 53 | 5 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-06 | 173 | 53 | 5 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-06 | 197 | 53 | 5 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.57e-05 | 156 | 53 | 4 | 53ded973358e3e48054130131e959f0d1f4ef60f | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_2|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.44e-05 | 165 | 53 | 4 | 731147b4337fd0de4383dc8170b4f9ccd98caec6 | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 4.99e-05 | 170 | 53 | 4 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | BAL-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 6.92e-05 | 185 | 53 | 4 | e867ed55ab0df018f14bca824da09d36d83e12f9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.52e-05 | 189 | 53 | 4 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-05 | 194 | 53 | 4 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Control-PLT_1|Control / Disease Group and Platelet Clusters | 8.49e-05 | 195 | 53 | 4 | 20ee45983a5675d9fa072d02dd45c6ce8662d7d7 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Deuterosomal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-05 | 197 | 53 | 4 | 861e8df9bd74dc5e17bafdc1fb3fef546753c73a | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.18e-05 | 199 | 53 | 4 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 9.36e-05 | 200 | 53 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | mild-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.36e-05 | 200 | 53 | 4 | c825320599a61a4c629d736f5c0fd6f1f405540a | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.36e-05 | 200 | 53 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 9.36e-05 | 200 | 53 | 4 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.47e-04 | 115 | 53 | 3 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.47e-04 | 115 | 53 | 3 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.47e-04 | 115 | 53 | 3 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-6|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 5.19e-04 | 132 | 53 | 3 | b7611c6a5c86908132e7ab3e41d67277e8142db1 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 5.91e-04 | 138 | 53 | 3 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.04e-04 | 139 | 53 | 3 | 6396434c1cb209193ccdf15581ec2adacf941d85 | |
| ToppCell | metastatic_Brain-T/NK_cells-Naive_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 7.10e-04 | 147 | 53 | 3 | 4f7a0c287721befeffabf95b8c5f9ff64149c7c1 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.24e-04 | 148 | 53 | 3 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.24e-04 | 148 | 53 | 3 | 065177aaa63c0441d312260b43ecdac78c84ad03 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.24e-04 | 148 | 53 | 3 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.53e-04 | 150 | 53 | 3 | aa11579a57d671a55e64183d35c1340fda6dec14 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 7.68e-04 | 151 | 53 | 3 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.97e-04 | 153 | 53 | 3 | 82b77c8bae49dd63b8f10eb67df66ca71d0bb315 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.97e-04 | 153 | 53 | 3 | 7480522a47e367f8facc4f5d599fbaf0b5ad4007 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.13e-04 | 154 | 53 | 3 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.13e-04 | 154 | 53 | 3 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.13e-04 | 154 | 53 | 3 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.13e-04 | 154 | 53 | 3 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.28e-04 | 155 | 53 | 3 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.28e-04 | 155 | 53 | 3 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.43e-04 | 156 | 53 | 3 | abea3c183d32062b009a79a2bdf861021989c7ef | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.59e-04 | 157 | 53 | 3 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | Adult-Immune-mast_cell-D175|Adult / Lineage, Cell type, age group and donor | 8.91e-04 | 159 | 53 | 3 | 9f53fe2e0f25448d62a591c8e528e9a49b5400d5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.07e-04 | 160 | 53 | 3 | 778faada072e3abfa76a9a06fd4885fb63de7902 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-1|TCGA-Kidney / Sample_Type by Project: Shred V9 | 9.24e-04 | 161 | 53 | 3 | 6cacae4a759ace763597ee394cff498dc5d96f74 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.57e-04 | 163 | 53 | 3 | 1feb4ef7b8abcfca9a72c8d13c40548de79e7db2 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.92e-04 | 165 | 53 | 3 | 436ce4bc75e1ba4351c439ccad19f84ad5bcb92f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-04 | 165 | 53 | 3 | 50f1fa7434ebb777e15d5273d1ff41070cff6db3 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.92e-04 | 165 | 53 | 3 | 242bdb7654f415391fb8e9bdc06412c7eee9c97e | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-03 | 166 | 53 | 3 | f4698fd08965936d51695d571bd10fb77330d916 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 1.03e-03 | 167 | 53 | 3 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.04e-03 | 168 | 53 | 3 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-03 | 169 | 53 | 3 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-03 | 169 | 53 | 3 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 169 | 53 | 3 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.08e-03 | 170 | 53 | 3 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.08e-03 | 170 | 53 | 3 | 0f215911b5880eeffeb43230f7eeaf55b612eaf2 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-03 | 172 | 53 | 3 | f814b6134ad608015765399d54cc1e5e1873ed34 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-03 | 172 | 53 | 3 | 7295bf3ae21a61dd6bcfa0dfb7a37d0f3e8f94ab | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-03 | 172 | 53 | 3 | e9b97f37bb1732ad9aa89c5e9b513d14022801ac | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-03 | 173 | 53 | 3 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-03 | 175 | 53 | 3 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_26.46.91|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-03 | 176 | 53 | 3 | 29b71369503719c74888cd356ceb6724cfdcabd9 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-03 | 176 | 53 | 3 | 1dd54bfaa58541de51e5a8328651d390833bd480 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-03 | 176 | 53 | 3 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-03 | 177 | 53 | 3 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-03 | 177 | 53 | 3 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.21e-03 | 177 | 53 | 3 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | Severe-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.23e-03 | 178 | 53 | 3 | b7374a97c51239782bed658381a02cb1b3d9bf66 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.23e-03 | 178 | 53 | 3 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-03 | 178 | 53 | 3 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 1.23e-03 | 178 | 53 | 3 | d8e0a696bdd6af6422d72af0413f9dbd6bc02afa | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 1.23e-03 | 178 | 53 | 3 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.23e-03 | 178 | 53 | 3 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | FF-Differ-KC|World / shred by cell class for mouse tongue | 1.25e-03 | 179 | 53 | 3 | 1526a130565a97c291a25a7a988089bffc1515c1 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.25e-03 | 179 | 53 | 3 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-03 | 180 | 53 | 3 | 18bf8561ad3aa9787d2a8ef942a96f641734c608 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-03 | 180 | 53 | 3 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | wk_15-18-Hematologic-Myeloid-APOE+_Mac2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.27e-03 | 180 | 53 | 3 | c630a121aedd09a51ea18cc6e8552eb979e5b555 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-03 | 181 | 53 | 3 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-03 | 181 | 53 | 3 | a6c8b33a392de3df2f179317e329e45d3d8c6f52 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.29e-03 | 181 | 53 | 3 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 1.31e-03 | 182 | 53 | 3 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.31e-03 | 182 | 53 | 3 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-03 | 182 | 53 | 3 | 41f1749e2368397bca49143786da0423792f03bd | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 1.31e-03 | 182 | 53 | 3 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-03 | 182 | 53 | 3 | 9174fb0b7ed8f721a5c513e41fd80476a9f34332 | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.31e-03 | 182 | 53 | 3 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-03 | 183 | 53 | 3 | 547b1fb9f9940cfc8d6e351d96acc0da44def57e | |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | 1.34e-03 | 183 | 53 | 3 | b177be283e1553fb1f69a346f1ba79ad00297fa2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-03 | 183 | 53 | 3 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 1.34e-03 | 183 | 53 | 3 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-03 | 183 | 53 | 3 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-03 | 183 | 53 | 3 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-03 | 184 | 53 | 3 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_12|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-03 | 184 | 53 | 3 | b8ecf58b3bdb25bcba5efc2d764930bb84ab95c8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-03 | 184 | 53 | 3 | 7d41784eac0935e77d6bc701f20c693adf998730 | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.36e-03 | 184 | 53 | 3 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 1.36e-03 | 184 | 53 | 3 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_12|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.36e-03 | 184 | 53 | 3 | b232a9cc1d14e1a134b037016d437b93921a4a0f | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.36e-03 | 184 | 53 | 3 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.36e-03 | 184 | 53 | 3 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.38e-03 | 185 | 53 | 3 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| Disease | Malignant mesothelioma | 9.50e-04 | 109 | 52 | 3 | C0345967 | |
| Disease | Alzheimer disease, polygenic risk score | 3.66e-03 | 586 | 52 | 5 | EFO_0030082, MONDO_0004975 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VEKKPRTFIIKLIKW | 136 | Q9UBJ2 | |
| FKLPKWRVKGKTIKE | 76 | Q3SY69 | |
| KKEPAVLELEGKKWR | 316 | Q01518 | |
| EKLPQEWKKKSLIQK | 3866 | Q96DT5 | |
| PETIKCLKKSNIKIW | 746 | O60423 | |
| VVVKLLPEEHWKVVK | 111 | Q8IYB7 | |
| KNVIKKKGEIIILWT | 1916 | Q9UKL3 | |
| SVDKWGKPLVIDKLK | 411 | Q709F0 | |
| ELIIGKKFKLPVWET | 61 | O00170 | |
| QAWDVGPVRLKKKVK | 686 | Q8TDY8 | |
| IKQKRKEKAGKWEVP | 106 | O95478 | |
| KEKAGKWEVPLPKVR | 111 | O95478 | |
| IIVWEKKPTVEEKAK | 2711 | P49792 | |
| KVKIPEELKPWLVDD | 196 | Q9UBU8 | |
| EKLIIWKIALSPITK | 121 | Q8WUM0 | |
| EVVIPKKKTWDKVAV | 56 | Q96EY7 | |
| GLPKEKAIKKIWLVD | 321 | P48163 | |
| KAIKKIWLVDSKGLI | 326 | P48163 | |
| KLQEKWSLKTPEIQK | 4416 | Q03001 | |
| KAEVILGSIIKKKGW | 146 | Q14722 | |
| SIPWKVLKVVAKVIR | 396 | O94919 | |
| VKKLTKLWKENPGLV | 166 | Q92616 | |
| IWTIIPKKLGKVNIT | 846 | Q6IE36 | |
| LWLTKTKLIEGLPEK | 121 | Q9BZE1 | |
| PRKEIIVWKKNKSIV | 61 | O43927 | |
| TIIPEKLKPWVRAKK | 96 | Q9GZU2 | |
| QKWITEEKPEVPDKK | 481 | Q9C0G6 | |
| KKIVWLKLLIPKITG | 111 | A0A1W2PR19 | |
| KVPRLKTWLLSEKKG | 26 | Q9NRX6 | |
| IKWVDGAKPLLKIKS | 801 | Q5JSL3 | |
| KLKVKVKIGASWGEL | 2571 | O75417 | |
| EGIGKWEPWIKKLKE | 1921 | Q8WXX0 | |
| LKLWILTKLPGEMEK | 221 | Q5VWZ2 | |
| KGIKVVGKWKEVKID | 21 | Q9GZR7 | |
| IKNWKELPAVLEKEK | 386 | Q9Y2B1 | |
| RIGVWATKPILKGKK | 41 | Q13029 | |
| DVKLKLKQSIEWPLK | 471 | Q9BVQ7 | |
| VKEKVGGKQPDKIWI | 1536 | Q9HCM1 | |
| CGLVWVPIIKKKQKH | 106 | P0C851 | |
| GKVKKLDKWVPHELT | 451 | Q53H47 | |
| GLTIKPLVKWLKVKR | 446 | Q14940 | |
| LVKPEVWTLKEKCIL | 106 | Q9UL46 | |
| KWVGVLSELHKILKK | 1191 | Q5VT25 | |
| IISKEKKEIKWIGLP | 196 | Q14188 | |
| IISKEKKEIKWIGLP | 181 | Q14186 | |
| LKAVWKIKELPLKKD | 176 | Q8NHY6 | |
| PILIKVAWKKAAKRK | 606 | P50443 | |
| KPERKIQFKEKVLWT | 21 | P61619 | |
| KGIRPKKKTNLVWDE | 121 | Q15050 | |
| KVWDIVGTELKLKKE | 501 | Q6Q0C0 | |
| EQQKWVSRLVKKIPK | 1336 | O75116 | |
| WPKQSKIILKIGAVV | 186 | Q3KNW5 | |
| KIEIKLKKPEAVRWE | 241 | Q9Y2Z0 | |
| KRVNEWKTPGKKTIV | 531 | Q15393 | |
| KKKALIIIWAKVLQP | 66 | P57678 | |
| PLVLKLKKLVNEDKW | 106 | P20591 |